Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
3,568
Views
13
CrossRef citations to date
0
Altmetric
Coronaviruses

Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV

Qian Wanga Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Ziyang Songa Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;d Shanghai Institute of Biological Products Co., Ltd., China National Biotec Group, Shanghai, People's Republic of China
,
Jinghuan Yanga Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;e Beijing Institute of Biological Products Co., Ltd., China National Biotec Group, Beijing, People's Republic of China
,
Qian Hea Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Qunying Maoa Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Yu Baia Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Jianyang Liua Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Chaoqiang Ana Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;f Minhai Biotechnology Co., Ltd., Beijing, People’s Republic of China
,
Xujia Yana Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;g Changchun Institute of Biological Products Co., Ltd., China National Biotec Group, Changchun, People's Republic of China
,
Bopei Cuia Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;h Wuhan Institute of Biological Products Co., Ltd., China National Biotec Group, Wuhan, People's Republic of China
,
Lifang Songa Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China
,
Dong Liua Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of China;g Changchun Institute of Biological Products Co., Ltd., China National Biotec Group, Changchun, People's Republic of China
,
Miao Xua Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of ChinaCorrespondence[email protected]
&
Zhenglun Lianga Hepatitis virus and enterovirus vaccines Division, National Institutes for Food and Drug Control, Beijing, People’s Republic of China;b NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing, People's Republic of China;c NMPA Key Laboratory for Quality Research and Evaluation of Biological Products, Beijing, People's Republic of ChinaCorrespondence[email protected]
 show all
Pages 1145-1153 | Received 19 Jan 2022, Accepted 25 Mar 2022, Published online: 18 Apr 2022

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Li Qin, Yuanyuan Zuo, Shuying Liu, Bingxiang Li, Hongye Wang, Heng Li, Jing Li, Yanli Chen, Ming Sun & Huiwen Zheng. (2022) Different T-cell and B-cell repertoire elicited by the SARS-CoV-2 inactivated vaccine and S1 subunit vaccine in rhesus macaques. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (12)

Guanhua Zha, Zhiwei Chen, Na Wu, Tianquan Huang, Zhiling Deng, Dachuan Cai, Mingli Peng, Peng Hu & Hong Ren. (2024) Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study. Journal of Medical Virology 96:3.
Crossref
Liang Wang, Di Liu, Hong Ma, Dongjie Zhang, Xinmiao He, Wentao Wang, Bo Fu, Zhongqiu Li & Zhenhua Guo. (2024) TAP2 Effect on Min-Pig Stromal Vascular Fraction Cell Gene Expression. Cytology and Genetics 58:1, pages 60-69.
Crossref
Mohamed A. Wahba, Dina Mofed, Doaa A. Ghareeb, Jihad I. Omran & Tamer Z. Salem. (2023) Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model. Journal of Genetic Engineering and Biotechnology 21:1, pages 16.
Crossref
Jiaying Zheng, Jiahui Yang, Zemiao Zhang, Xia Liang, Shijia Liu, Ying Pan, Jingguang Wei, Youhua Huang, Xiaohong Huang & Qiwei Qin. (2023) An improved oral vaccine with molecular adjuvant β-defensin protects grouper against nervous necrosis virus infection. Fish & Shellfish Immunology 136, pages 108709.
Crossref
Yu Bai, Chaoqiang An, Xuanxuan Zhang, Kelei Li, Feiran Cheng, Bopei Cui, Ziyang Song, Dong Liu, Jialu Zhang, Qian He, Jianyang Liu, Qunying Mao & Zhenglun Liang. (2023) A Novel Targeted RIG-I Receptor 5′Triphosphate Double Strain RNA-Based Adjuvant Significantly Improves the Immunogenicity of the SARS-CoV-2 Delta-Omicron Chimeric RBD-Dimer Recombinant Protein Vaccine. Viruses 15:5, pages 1099.
Crossref
Sonia Marquez-Martinez, Aneesh Vijayan, Selina Khan & Roland Zahn. (2023) Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines. Current Opinion in Immunology 80, pages 102282.
Crossref
Yu Bai, Dong Liu, Qian He, Jianyang Liu, Qunying Mao & Zhenglun Liang. (2023) Research progress on circular RNA vaccines. Frontiers in Immunology 13.
Crossref
Jialu Zhang, Qian He, Xujia Yan, Jianyang Liu, Yu Bai, Chaoqiang An, Bopei Cui, Fan Gao, Qunying Mao, Junzhi Wang, Miao Xu & Zhenglun Liang. (2022) Mixed formulation of mRNA and protein‐based COVID‐19 vaccines triggered superior neutralizing antibody responses. MedComm 3:4.
Crossref
Huan Meng, Shuang Wang, Xiaomeng Tang, Jingjing Guo, Xinming Xu, Dagang Wang, Fangfang Jin, Mei Zheng, Shangqi Yin, Chaonan He, Ying Han, Jin Chen, Jinyu Han, Chaobo Ren, Yantao Gao, Huifang Liu, Yajie Wang & Ronghua Jin. (2022) Respiratory immune status and microbiome in recovered COVID-19 patients revealed by metatranscriptomic analyses. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Yuwei Zhang, Mingxiao Yao, Xingyu Guo, Shanshan Han, Shu Zhang, Jinzhong Zhang, Xiangkun Jiang, Jianxing Wang, Ming Fang, Shuang Wang, Bo Pang, Xiaolin Liu, Zengqiang Kou & Xiaolin Jiang. (2022) Humoral immunity and transcriptome differences of COVID-19 inactivated vacciane and protein subunit vaccine as third booster dose in human. Frontiers in Immunology 13.
Crossref
Dong Liu, Chaoqiang An, Yu Bai, Kelei Li, Jianyang Liu, Qian Wang, Qian He, Ziyang Song, Jialu Zhang, Lifang Song, Bopei Cui, Qunying Mao, Wei Jiang & Zhenglun Liang. (2022) A Novel Single-Stranded RNA-Based Adjuvant Improves the Immunogenicity of the SARS-CoV-2 Recombinant Protein Vaccine. Viruses 14:9, pages 1854.
Crossref
Nur Asheila Abdul Taib, Dhesi Baha Raja, Alvin Kuo Jing Teo, Adeeba Kamarulzaman, Timothy William, Arvinder-Singh HS, Siti Aisah Mokhtar, Choo-Yee Ting, Wei Aun Yap, Michelle Yoon Kim Chan & Lidwina Edwin Amir. (2022) Comparison of vaccine efficacy must be based on good clinical data–Authors’ reply. The Lancet Regional Health - Western Pacific 20, pages 100413.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.